| Literature DB >> 18345301 |
George Barreto1, Parul J Shukla, Mukta Ramadwar, Supreeta Arya, Shailesh V Shrikhande.
Abstract
Pancreatic carcinoma accounts for the most dismal survival among all malignancies with 5-year survival rates approaching 5%. The reason for this, besides the inherent biologic nature of the disease, is the fact that the patients tend to present late in the disease. We present a review of the current published data on cystic neoplasms of the pancreas, which though rare, constitute an important subgroup of pancreatic neoplasms that have a better prognosis and are potentially curable lesions.Entities:
Keywords: cystic tumours; intraductal papillary mucinous neoplasm of the pancreas (IPMN); mucinous cystadenoma; pancreas; serous cystadenoma
Year: 2007 PMID: 18345301 PMCID: PMC2215393 DOI: 10.1080/13651820701435287
Source DB: PubMed Journal: HPB (Oxford) ISSN: 1365-182X Impact factor: 3.647